InvestorsObserver is giving Codex DNA Inc (DNAY) an Analyst Rating Rank of 74, meaning DNAY is ranked higher by analysts than 74% of stocks. The average price target for DNAY is $25 and analyst’s rate the stock as a Strong Buy.
Why are Analyst Ratings Important?
A company’s financial statements are a significant factor weighted by experts when analyzing a company’s health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What’s Happening With Codex DNA Inc Stock Today?
Codex DNA Inc (DNAY) stock is trading at $9.75 as of 11:10 AM on Tuesday, Jan 11, a decline of -$0.07, or -0.71% from the previous closing price of $9.82. The stock has traded between $9.55 and $9.89 so far today. Volume today is below average. So far 134,706 shares have traded compared to average volume of 951,605 shares.